EA-230

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameEA-230
Drug Alias NameNMPF-46EA-230Peptide-46Peptide-EA-230
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSystemic Inflammatory Response SyndromeCoronary Artery DiseaseRenal Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesExponential Biotherapies IncBiotempt
China Registration ClassN/A

Develop Information

Active CompaniesEBI Anti Sepsis BVBiotemptExponential Biotherapies Inc
Inactive CompaniesRadboud University Medical Center
Active IndicationsCoronary Artery DiseaseRenal Insufficiency
Inactive IndicationsSystemic Inflammatory Response SyndromeEndotoxemia

Other Information

ATC CodeN/A
Related LinksN/A